{"transactions":[{"id":4300324,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2017-05-31T22:49:27.000Z","date":"2017-05-31","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":38800,"derivative":{"exercise_price":44.615,"exercise_date":"2012-05-12","expiration_date":"2018-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001225208-17-010625","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010625/doc4.xml","form_type":"4"}},{"id":4300323,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-31T22:49:27.000Z","date":"2017-05-31","kind":"sale","acquired":false,"shares":10000,"price":114.876,"value":1148760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $114.7519 to $115.00.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":129137.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-010625","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010625/doc4.xml","form_type":"4"}},{"id":4300322,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-31T22:49:27.000Z","date":"2017-05-31","kind":"exercise","acquired":true,"shares":10000,"price":44.615,"value":446150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":139137.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-010625","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010625/doc4.xml","form_type":"4"}},{"id":4312216,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2017-05-19T20:25:08.000Z","date":"2017-05-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":48800,"derivative":{"exercise_price":44.615,"exercise_date":"2012-05-12","expiration_date":"2018-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001225208-17-010120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010120/doc4.xml","form_type":"4"}},{"id":4312215,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2017-05-19T20:25:08.000Z","date":"2017-05-17","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":58800,"derivative":{"exercise_price":44.615,"exercise_date":"2012-05-12","expiration_date":"2018-05-11","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001225208-17-010120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010120/doc4.xml","form_type":"4"}},{"id":4312214,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-19T20:25:08.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":10000,"price":113.1346,"value":1131346.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $113.00 to $113.21.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":129137.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-010120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010120/doc4.xml","form_type":"4"}},{"id":4312213,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-19T20:25:08.000Z","date":"2017-05-19","kind":"exercise","acquired":true,"shares":10000,"price":44.615,"value":446150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":139137.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-010120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010120/doc4.xml","form_type":"4"}},{"id":4312212,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-19T20:25:08.000Z","date":"2017-05-17","kind":"sale","acquired":false,"shares":8000,"price":113.1526,"value":905220.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $113.1340 to $113.1550.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":129137.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-010120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010120/doc4.xml","form_type":"4"}},{"id":4312211,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-19T20:25:08.000Z","date":"2017-05-17","kind":"sale","acquired":false,"shares":4631,"price":113.2092,"value":524271.8052,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $113.2091 to $113.2150.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":137137.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-010120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010120/doc4.xml","form_type":"4"}},{"id":4312210,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-19T20:25:08.000Z","date":"2017-05-17","kind":"exercise","acquired":true,"shares":8000,"price":44.615,"value":356920.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":141768.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-010120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817010120/doc4.xml","form_type":"4"}},{"id":4321457,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2017-05-15T22:34:37.000Z","date":"2017-05-12","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":66800,"derivative":{"exercise_price":44.615,"exercise_date":"2012-05-12","expiration_date":"2018-05-11","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001225208-17-009815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009815/doc4.xml","form_type":"4"}},{"id":4321456,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-15T22:34:37.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":2600,"price":113.134,"value":294148.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":133768.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-009815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009815/doc4.xml","form_type":"4"}},{"id":4321455,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-15T22:34:37.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":1900,"price":113.13,"value":214947.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":136368.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-009815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009815/doc4.xml","form_type":"4"}},{"id":4321454,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-15T22:34:37.000Z","date":"2017-05-12","kind":"sale","acquired":false,"shares":7000,"price":110.676,"value":774732.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":138268.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-009815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009815/doc4.xml","form_type":"4"}},{"id":4321453,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-15T22:34:37.000Z","date":"2017-05-12","kind":"exercise","acquired":true,"shares":7000,"price":44.615,"value":312305.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person."}],"balance_after":145268.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-009815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009815/doc4.xml","form_type":"4"}},{"id":4323358,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Performance Rights","published_at":"2017-05-12T23:11:17.000Z","date":"2017-05-10","kind":"exercise","acquired":false,"shares":9625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form."},{"field":"shares","element":"transactionShares","label":"F1","text":"On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":0,"derivative":{"expiration_date":"2017-05-31","underlying":"Common Stock","underlying_shares":9625},"source":{"system":"sec-edgar","filing":"0001225208-17-009628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009628/doc4.xml","form_type":"4"}},{"id":4323357,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-12T23:11:17.000Z","date":"2017-05-10","kind":"tax_withholding","acquired":false,"shares":494,"price":110.58,"value":54626.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":138268.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-009628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009628/doc4.xml","form_type":"4"}},{"id":4323356,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-05-12T23:11:17.000Z","date":"2017-05-10","kind":"exercise","acquired":true,"shares":9625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":138762.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-009628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009628/doc4.xml","form_type":"4"}},{"id":4342469,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2017-04-28T21:10:50.000Z","date":"2017-04-27","kind":"exercise","acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 10, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":25.48,"exercise_date":"2011-05-13","expiration_date":"2017-05-12","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001225208-17-008604","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817008604/doc4.xml","form_type":"4"}},{"id":4342468,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-04-28T21:10:50.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":9659,"price":109.3268,"value":1055987.5612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 10, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $108.83 to $109.82.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.  This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator."}],"balance_after":129137.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-008604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817008604/doc4.xml","form_type":"4"}},{"id":4342467,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-04-28T21:10:50.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":7636,"price":110.0812,"value":840580.0432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 10, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $109.89 to $110.48.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.  This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator."}],"balance_after":138796.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-008604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817008604/doc4.xml","form_type":"4"}},{"id":4342466,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-04-28T21:10:50.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":6705,"price":108.3554,"value":726522.957,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 10, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $107.83 to $108.82.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.  This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator."}],"balance_after":146432.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-008604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817008604/doc4.xml","form_type":"4"}},{"id":4342465,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-04-28T21:10:50.000Z","date":"2017-04-27","kind":"exercise","acquired":true,"shares":24000,"price":25.48,"value":611520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 10, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.  This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator."}],"balance_after":153137.1496,"source":{"system":"sec-edgar","filing":"0001225208-17-008604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817008604/doc4.xml","form_type":"4"}},{"id":4365688,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2017-04-03T21:09:34.000Z","date":"2017-03-30","kind":"exercise","acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 10, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":24000,"derivative":{"exercise_price":25.48,"exercise_date":"2011-05-13","expiration_date":"2017-05-12","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001225208-17-007147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817007147/doc4.xml","form_type":"4"}},{"id":4365687,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-04-03T21:09:34.000Z","date":"2017-03-30","kind":"sale","acquired":false,"shares":24000,"price":93.8958,"value":2253499.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 10, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $93.64 to $94.64.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":128906.2936,"source":{"system":"sec-edgar","filing":"0001225208-17-007147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817007147/doc4.xml","form_type":"4"}},{"id":4365686,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":175664,"kind":"person","name":"Verguet Patrick B","position":1,"cik":"0001308771","reported_name":"Verguet Patrick B","relationship":{"officer":true,"officer_title":"CVP, Europe"}}],"security":"Common Stock","published_at":"2017-04-03T21:09:34.000Z","date":"2017-03-30","kind":"exercise","acquired":true,"shares":24000,"price":25.48,"value":611520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 10, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":152906.2936,"source":{"system":"sec-edgar","filing":"0001225208-17-007147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817007147/doc4.xml","form_type":"4"}}]}